ARCL Organics profit and loss

Latest FY25

Revenue: ₹251cr
EBITDA: ₹23.8cr
Net profit: ₹11.8cr
EPS: ₹14.69

₹ crore except per share

Tap a line for its trend	FY25Mar 2025

Expenses
	251
	179
	−6.0
	12.4
	4.9
	5.2
	29.7
	237
	23.8
	18.5
Profit
	16.0
	2.9
	1.4
	4.3
	11.8
	−0.4
	11.4
Per share
	₹14.69
	₹14.69
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	77.7
	31.0%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ARCL₹213.86

ARCL Organics Limited

· Chemicals

Annual Quarterly₹ CrorePeersAMAL CHEMCRUX DAICHI ELANTAS GRAUWEIL INDOKEM JYOTIRES KANCHIMcap ₹171 Cr

View

	In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025
	Revenue from Operations	250.6
	Expenses
	+ Cost of Materials Consumed	178.8
	+ Purchases of Stock-in-Trade	-6.0
	+ Employee Benefit Expense	12.4
	+ Finance Costs	4.9
	+ Depreciation & Amortisation	5.2
	+ Other Expenses	29.7
	Total Expenses	236.9
	EBITDA	23.8
	EBIT	18.5
	Profit
	Pretax Income	16.0
	+ Current Tax	2.9
	+ Deferred Tax	1.4
	Tax Expense	4.3
	Net Income	11.8
	+ Other Comprehensive Income	-0.4
	Total Comprehensive Income	11.4
	Per Share
	Basic EPS	14.69
	Diluted EPS	14.69
	Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
	Gross Profit	77.7
	Gross Margin %	31.02

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.